Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Xenetic Biosciences, Inc. - Common Stock (NQ:XBIO)

3.980 +0.120 (+3.11%)
Streaming Delayed Price Updated: 2:58 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 65,512
Open 3.980
Bid (Size) 3.910 (1)
Ask (Size) 4.040 (9)
Prev. Close 3.860
Today's Range 3.800 - 4.150
52wk Range 2.200 - 13.93
Shares Outstanding 1,542,139
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges
Benzinga Edge Stock Rankings evaluate companies across four key factors. Here are three big companies that stood out this week. 
Via Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill

Performance

YTD
-1.7%
-1.7%
1 Month
+23.2%
+23.2%
3 Month
+9.3%
+9.3%
6 Month
+47.7%
+47.7%
1 Year
+10.6%
+10.6%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Which stocks are experiencing notable movement on Friday?
Via Chartmill
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock
Via ACCESS Newswire
4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings
Via Benzinga
Which stocks are moving before the opening bell on Thursday?
Via Chartmill
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
MAGA Stocks Undercard: MYSE, XBIO, ATON, ACXP, RDZN – Innovators Driving Next Tech, Blockchain, AI Wave – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Gains 150 Points; US Mortgage Applications Decline
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results
Via ACCESS Newswire
Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma
Via ACCESS Newswire
Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
Via ACCESS Newswire
Xenetic Biosciences, Inc. Announces Update from Collaboration Partner of First Patient Dosed in Exploratory Clinical Study of DNase I in Combination with FOLFIRINOX for the First Line Treatment of Unresectable, Locally Advanced or Metastatic Pancreatic
Via ACCESS Newswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
Via ACCESS Newswire
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Via ACCESS Newswire
Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma
Via ACCESS Newswire
Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results
Via ACCESS Newswire
Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses
Via ACCESS Newswire
Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting
Via ACCESS Newswire

Frequently Asked Questions

Is Xenetic Biosciences, Inc. - Common Stock publicly traded?
Yes, Xenetic Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Xenetic Biosciences, Inc. - Common Stock trade on?
Xenetic Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Xenetic Biosciences, Inc. - Common Stock?
The ticker symbol for Xenetic Biosciences, Inc. - Common Stock is XBIO on the Nasdaq Stock Market
What is the current price of Xenetic Biosciences, Inc. - Common Stock?
The current price of Xenetic Biosciences, Inc. - Common Stock is 3.980
When was Xenetic Biosciences, Inc. - Common Stock last traded?
The last trade of Xenetic Biosciences, Inc. - Common Stock was at 10/24/25 02:58 PM ET
What is the market capitalization of Xenetic Biosciences, Inc. - Common Stock?
The market capitalization of Xenetic Biosciences, Inc. - Common Stock is 6.14M
How many shares of Xenetic Biosciences, Inc. - Common Stock are outstanding?
Xenetic Biosciences, Inc. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.